Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Starpharma Holdings Signs DEP Research Agreement with Genentech

07 Dec 2021  |  09:16:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Starpharma signs DEP Research Agreement with US Biopharma Co

Starpharma Holdings announced that it has signed an exploratory DEP Research Agreement with Genentech, a member of the Roche Group, with an initial focus on evaluating DEP (dendrimer based) drug conjugates. It also has a number of existing DEP partnerships with international pharmaceutical companies, including AstraZeneca, Merck & Co, Chase Sun, as well as several undisclosed partnerships.

Please click here for full details

See more ASX300 News Announcements